Clinical significance of Helicobacter infection in children

M Rowland1, B Drumm

  • 1Department of Paediatrics, University College Dublin, Ireland.

Insights

Childhood Helicobacter pylori infection is common globally, especially in developing nations. Early treatment is crucial as it

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Epidemiology

Background:

  • Helicobacter pylori (H. pylori) infection is a primary cause of chronic gastritis, peptic ulcers, and gastric cancer in adults.
  • H. pylori infection is predominantly acquired during childhood, with prevalence varying significantly by socioeconomic status and geographic region.
  • While often asymptomatic in children, H. pylori infection is linked to duodenal ulcer disease and is a risk factor for gastric carcinoma.

Purpose of the Study:

  • To investigate the epidemiological characteristics of H. pylori infection in children.
  • To understand the implications of childhood H. pylori acquisition on long-term health outcomes.
  • To evaluate current treatment strategies and identify the need for clinical guidelines in pediatric H. pylori management.

Main Methods:

  • Review of epidemiological data on H. pylori prevalence in pediatric populations worldwide.
  • Analysis of the association between H. pylori infection and gastrointestinal diseases in children.
  • Evaluation of a specific treatment regimen for H. pylori in children.

Main Results:

  • H. pylori prevalence in children ranges from 10% in developed countries to 80-100% in developing countries.
  • Infection in children is a significant risk factor for developing gastric carcinoma later in life.
  • A one-week triple therapy regimen (colloidal bismuth subcitrate, metronidazole, clarithromycin) shows efficacy, emphasizing the importance of patient compliance.

Conclusions:

  • Childhood H. pylori infection is a critical public health concern with long-term sequelae.
  • Further research is needed to determine optimal treatment guidelines and address unanswered epidemiological questions.
  • A consensus on the necessity and approach to treating H. pylori in children is urgently required.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...